Health

Pharmaceuticals and Vaccines

  • Pharmaceuticals and Vaccines
    CFR Symposium Backgrounder on Food and Drugs
    Laurie Garrett and Yanzhong Huang provide a backgrounder for the CFR Symposium, Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization? Every aspect of the world's food, drug, …
  • Global
    Potential Solutions
    Play
    LAURIE GARRETT: I'd like to encourage people to please take your seats. Perhaps someone at the back there could let people who are still noshing know that it is time to cease the noshing and come …
  • Global
    Policy Challenges in a Globalized Era
    Play
    (Mr. Barbano's remarks are provided through interpreter.) SUSAN DENTZER: Good morning. I'm Susan Dentzer from Health Affairs. I have the honor to be moderating our next panel -- our first panel,…
  • Global
    The Scale of the Challenge: Overview and Case Studies
    Play
    RICHARD N. HAASS: Okay, if I could ask people to take their seats, including Ms. Hamburg. Well, good morning. Welcome to the Council on Foreign Relations. Welcome to this temporary respite from t…
  • Global
    Food and Drug Safety: Potential Solutions
    Play
    Experts explore solutions for food and drug safety including stronger sanctions against organized crime, increased surveillance and monitoring of facilities, and better inter-country communication. This session was part of CFR's Symposium on Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization? which was sponsored by CFR's International Institutions and Global Governance Program and made possible through generous support from the Robina Foundation.
  • Global
    Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization?
    Play
    Session OneThe Scale of the Challenge: Overview and Case StudiesWelcoming Remarks: Richard N. Haass, President, Council on Foreign RelationsOpening Remarks: Margaret Hamburg, Commissioner, U.S. Food and Drug AdministrationDavid Heymann, Head and Senior Fellow, Centre on Global Health Security, Chatham House, United KingdomGary Jay Kushner, Partner and Leader, Food and Agriculture Practice Area, Hogan Lovells US, LLPPaul B. Orhii, Director General, National Agency for Food and Drug Administration and Control, NigeriaPresider: Richard E. Besser, Chief Health and Medical Editor, ABC News8:15 to 9:00 AM Breakfast Reception9:00 to 10:30 AM Meeting Session TwoPolicy Challenges in a Globalized EraDirceu Barbano, Director-President, National Agency of Sanitary Surveillance, BrazilMargaret Hamburg, Commissioner, U.S. Food and Drug AdministrationHoward Zucker, Senior Adviser, Division of Global Health and Human Rights, Massachusetts General Hospital; Former Assistant Director-General, World Health Organization Presider: Susan Dentzer, Editor-in-Chief, Health Affairs10:45 AM to 12:00 PM Meeting Session ThreePotential SolutionsCaroline Smith DeWaal, Food Safety Director, Center for Science in the Public InterestAline Plançon, Head of INTERPOL-IMPACT Project and Head of Medical Products Counterfeiting, and Pharmaceutical Crime Unit (MPCPC), INTERPOL, FranceMichael Robach, Vice President, Corporate Food Safety and Regulatory Affairs, Cargill, Inc.Greg Simon, Senior Vice President, Worldwide Policy, Pfizer, Inc. Presider and Closing Remarks: Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations12:00 to 12:45 PM Lunch12:45 to 2:00 PM Meeting Related Reading: Backgrounder: Food and Drugs by Laurie Garrett and Yanzhong Huang  
  • Global
    Food and Drug Safety: Policy Challenges in a Globalized Era
    Play
    Experts review case studies that frame the complexities of the food and drug supply chains and the policies which need to be addressed in order to protect consumers from fraud and food outbreaks. This session was part of CFR's Symposium on Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization? which was sponsored by CFR's International Institutions and Global Governance Program and made possible through generous support from the Robina Foundation.
  • Global
    Food and Drug Safety: The Scale of the Challenge
    Play
    Experts discuss the implications of importing and exporting food, drugs, and other consumer products in a globalized economym, as well as how to manage the quality of these products. This session was part of CFR's Symposium on Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization? which was sponsored by CFR's International Institutions and Global Governance Program and made possible through generous support from the Robina Foundation.
  • Global
    Open Minds, Open Labs: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World
    Play
    This meeting is part of the CEO speaker series. This series provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.
  • Global
    Open Labs, Open Minds: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World
    Play
    VIJAY VAITHEESWARAN: Ladies and gentlemen, if we can please take our seats. Thank you very much. My name is Vijay Vaitheeswaran, of The Economist. It's my great pleasure this morning to welcome you…
  • Global
    Open Labs, Open Minds: Breaking Down the Barriers to Innovation and Access to Medicines in the Developing World
    Play
    Watch GlaxoSmithKline CEO Andrew Witty discuss steps GSK is taking to address neglected tropical diseases and to ensure access to vaccines in the developing world. This session was part of the Corporate Program's CEO Speaker series.
  • Global
    Pandemic Influenza: Science, Economics, and Foreign Policy: Foreign Policy
    Play
    LAURIE GARRETT: If people could please take their seats. Broadcast audience, we'll be starting momentarily. Good morning, I'm Laurie Garrett, here as a senior fellow at Council on Foreign Relat…
  • Global
    Pandemic Influenza: Science, Economics, and Foreign Policy: Session Three: Foreign Policy
    Play
    Watch experts discuss the U.S. foreign policy implications of a global pandemic including access to vaccinations and effects on trade. This session was part of a CFR symposium, Pandemic Influenza: Science, Economics, and Foreign Policy, which was cosponsored with Science Magazine.
  • Global
    Pandemic Influenza: Science, Economics, and Foreign Policy
    Play
    Session One: The ScienceArnold Monto, Professor, Epidemiology, University of MichiganPeter Palese, Professor and Chair, Microbiology, and Professor of Medicine, Infectious Diseases, Mount Sinai School of MedicineLone Simonsen, Research Professor and Research Director, Department of Global Health, George Washington UniversityPresider: Jon Cohen, Correspondent, Science Magazine8:00 to 8:30 AM Breakfast Reception8:30 to 9:45 AM Meeting Session Two:The EconomicsAndrew Yanzhong Huang, Director, Center for Global Health Studies, Seton Hall UniversityAndrew Jack, Pharmaceutical Correspondent, Financial TimesMichael Osterholm, Director, Center for Infectious Disease Research and Policy (CIDRAP), University of MinnesotaPresider: Robert Rubin, Former U.S. Secretary of the Treasury; Co-Chair, Council on Foreign Relations10:00 to 11:15 AM Meeting Session Three:Foreign PolicyHelen Branswell, Medical Reporter, Canadian PressJohn E. Lange, Senior Program Officer for Developing-Country Policy and Advocacy, Global Health Program, Bill and Melinda Gates FoundationPresider: Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations11:30 AM to 12:45 PM Meeting12:45 to 1:30 PM Lunch Reception
  • Public Health Threats and Pandemics
    Constraints Loom for Swine Flu Vaccine
    David Fedson, an international expert in flu vaccine policy, says the current distribution system could leave many developing countries without access to vaccines during a flu pandemic. Fedson suggests more attention be given to alternative drug therapies.